These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 17530685)
1. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus. Booth S; Chohan S; Curran JC; Karrison T; Schmitz A; Utset TO Arthritis Rheum; 2007 Jun; 57(5):845-50. PubMed ID: 17530685 [TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon. Rodriguez VE; Gonzalez-Pares EN; Rivera C P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096 [TBL] [Abstract][Full Text] [Related]
3. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects. Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633 [TBL] [Abstract][Full Text] [Related]
4. Haemorheological changes in patients with systemic lupus erythematosus do not seem to be related to thrombotic events. Vayá A; Murado J; Santaolaria M; Simó M; Micó L; Calvo J; Todolí J; Ricart JM Clin Hemorheol Microcirc; 2008; 38(1):23-9. PubMed ID: 18094455 [TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Calvo-Alén J; Alarcón GS; Tew MB; Tan FK; McGwin G; Fessler BJ; Vilá LM; Reveille JD; Arthritis Rheum; 2006 Jun; 54(6):1940-5. PubMed ID: 16729310 [TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome]. Sarzi-Puttini P; Atzeni F; Carrabba M Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154 [TBL] [Abstract][Full Text] [Related]
8. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
10. Rheological alterations and thrombotic events in patients with systemic lupus erythematosus. Vayá A; Calvo J; Alcalá C; Micó L; Todolí J; Ricart JM Clin Hemorheol Microcirc; 2012; 51(1):51-8. PubMed ID: 22240368 [TBL] [Abstract][Full Text] [Related]
11. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963 [TBL] [Abstract][Full Text] [Related]
13. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C Lupus; 2007; 16(10):810-6. PubMed ID: 17895304 [TBL] [Abstract][Full Text] [Related]
14. Symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis. Shahin AA; Mostafa H; Sami H; Shahin HA Z Rheumatol; 2003 Jun; 62(3):246-50. PubMed ID: 12827401 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. Goldberg RJ; Urowitz MB; Ibañez D; Nikpour M; Gladman DD J Rheumatol; 2009 Nov; 36(11):2454-61. PubMed ID: 19833754 [TBL] [Abstract][Full Text] [Related]
16. Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus. Costallat LT; Ribeiro CC; Annichino-Bizzacchi JM Sangre (Barc); 1998 Oct; 43(5):345-8. PubMed ID: 9868323 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of low-shear whole blood viscosity in hypertensive men. Ciuffetti G; Schillaci G; Lombardini R; Pirro M; Vaudo G; Mannarino E Eur J Clin Invest; 2005 Feb; 35(2):93-8. PubMed ID: 15667579 [TBL] [Abstract][Full Text] [Related]
18. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. Romero-Díaz J; García-Sosa I; Sánchez-Guerrero J J Rheumatol; 2009 Jan; 36(1):68-75. PubMed ID: 19012362 [TBL] [Abstract][Full Text] [Related]
19. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis? Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256 [TBL] [Abstract][Full Text] [Related]
20. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E Lupus; 2007; 16(5):324-8. PubMed ID: 17576733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]